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Approximately 25%
of the ACC’s mem-
bers describe them-
selves as interven-
tional cardiologists.
Clearly, they are an
important segment
of the ACC cardio-
vascular team.n the past few months interventional cardiologists have felt under fire with late-
breaking clinical trial results and various studies at scientific meetings—including
the European Society of Cardiology (ESC) in September 2006 and the ACC.07 in
arch 2007—challenging percutaneous coronary intervention (PCI) and the use of
tents. The negative feedback during these few months is especially difficult after several
ears in which interventional cardiologists have received extensive positive recognition
or the extraordinary achievements and contributions they have made in saving lives with
heir new techniques and innovative approaches.
Perhaps because some of the seemingly negative information was presented at an Ameri-
an College of Cardiology (ACC) meeting, some interventional cardiologists have expressed
oncerns about the value of ACC membership and have claimed that the ACC is no longer
nterested in representing interventional cardiology. Nothing could be further from the truth.
Approximately 25% of the ACC’s members describe themselves as interventional car-
iologists. Clearly, they are an important segment of the ACC cardiovascular team. The
CC has numerous strategies in place to increase value to all its members and in recent
ears, those strategies have focused extensively on interventional cardiologists.
nvesting in Intervention: i2 Summit
hree years ago, after commissioning an intensive study of how to add better value for our
nterventional members, the ACC Board of Trustees voted, at significant risk, to invest in a
ew interventional meeting—the Innovation in Intervention: i2 Summit 2006. The study
evealed a clear need for a well-planned meeting that presented information in a fair and
alanced fashion with quality live case demonstrations. The i2 Summit revitalized more than
he former ACC Interventional Spotlight portion of the ACC Scientific Session. With its
nnovative approaches, it has been the catalyst for bringing the annual meeting’s educational
rocesses in step with what other organizations had been doing.
Both i2 Summit 2006 and 2007 have been extraordinarily successful, and Drs. David
olmes, Bill Knopf, and Barry Uretsky are in the midst of planning i2 Summit 2008 and
ill once again provide the best possible educational program for interventional cardiology.
roviding External and Internal Support
iven the public confusion generated by the results of the COURAGE (Clinical Outcomes
tilizing Revascularization and Aggressive DruG Evaluation) trial presented at ACC.07 in
arch, the ACC issued a statement in early April that expressed the ACC’s support for
nterventional cardiology and the important advances that interventional cardiology provides
or patients. The statement was developed so that members could print and distribute it to
heir patients who had questions about PCI and stents for their particular conditions.
At Food and Drug Administration hearings in December 2006, official ACC testi-
ony called for a longitudinal database and unique patient identifiers to link patient
ecords across all health care facilities in part to help clarify possible issues regarding
tents and other implanted devices. We also addressed the need to avoid “data hyste-
ia”—the taking of small numbers and using them to project how they might affect hun-
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August 7, 2007:558–9 President’s Pagereds of thousands of patients. We stressed that it is our
ob to put the significance of research data into perspec-
ive for our patients.
In January 2008, the ACC will launch JACC: Cardio-
ascular Interventions to facilitate publication of important
nterventional articles. The Journal of the American College
f Cardiology ( JACC) has been unable to print all the ex-
ellent interventional articles it has received due to space
imitations. This new journal, under Spencer King as edi-
or-in-chief, will provide a larger venue for important ar-
icles from the interventional community—not in compe-
ition with, but in addition to—Catheterization and
ardiovascular Interventions, the journal of the Society for
ngiography and Cardiovascular Interventions (SCAI).
uilding Recognition and Partnerships
he ACC plans to hold a commemorative Gruentzig
eeting in September 2007 at Heart House to highlight
he 30th anniversary of Gruentzig’s first interventional
rocedure. It will highlight the tremendous value that
nterventional cardiology has contributed to advancing our
nowledge base and patient care. The ACC has invited
he SCAI to assist in the planning of this meeting, which
ill be scheduled so as to not conflict with the ESC or
ranscatheter Cardiovascular Therapeutics (TCT).
The ACC Board of Trustees is also entertaining the
dea of an interventional scientific council within the Col-
ege, similar to the two recently piloted sections for
omen in Cardiology and Adult Congenital Heart Dis-
ase and Pediatric Cardiology, both of which are flourish-
ng. If the Board decides to move forward on a section
or interventional cardiology, we will invite the SCAI to
e involved.
The ACC also believes that collaboration is important
o the cardiovascular profession and to the patients that
e serve. To that end, we have continued to make signif-
cant strides in building bridges with the leadership of
CAI. The ACC supports the work of SCAI and has recently
iscussed joint operational issues and better transparency of any
lanned interventional-related activities of the College. Com-
unication between our two organizations is headed in a direc-
ion that we both want. We face some huge battles for both
maging and interventional cardiology, and we must fight them
ith a common voice and pooled resources to have the force
eeded to win.
evisiting the COURAGE Issue
arlier we mentioned the COURAGE trial results at
CC.07. We would be remiss if we did not take this
pace to correct misinformation about the ACC’s han-
ling of an embargo break with regard to the COUR-
GE results. ACC bylaws require that embargo breaks
nd other issues concerning professionalism be reviewed
y the ACC Ethics Committee. When the embargo on
eleasing the trial results was broken by a couple of mem-
ers, the following occurred: 2immediately following ACC.07, those involved com-
municated their lack of intent for the break and their
contrition for the problems it created;
the ACC’s Ethics Committee, which includes inter-
ventional cardiologists, reviewed all available informa-
tion and unanimously concluded that the embargo had
been broken and recommended sanctions;
the Board of Trustees also discussed the Committee’s
recommendations and unanimously approved them.
he process by which the decision was achieved by our
ommittee volunteers was thoughtful and deliberate. Our
mbargo policies have been in place for a long time and be-
ause of some concerns raised during this process, we have
sked the Ethics Committee to review our current policy.
owever, we also realize that it is more important than ever
o provide balanced discussion of late-breaking clinical trial
esults that are likely to attract media and public attention,
nd we have put in place a means to accomplish this.
oving Forward
resident-Elect Doug Weaver, ACC CEO Jack Lewin,
nd I have spoken to several prominent interventionalists
o get their opinions and counsel on how we might im-
rove and help interventional cardiologists with their cur-
ent concerns. These calls have been warm, informative
or all parties, and productive in helping us modify proce-
ures and protocols in the College.
We can continue to spend time putting out fires, or we
an work together to build better and stronger programs that
enefit us all. ACC leadership knows your issues and con-
erns well and is working in every way possible to address
hem.
To that point, we are concerned about the most signifi-
ant risk to the profession and our patients, which is
ealth care reform. We need to commit our energy and
esources to address this issue and not the past. The
CC is using the credibility we have built on Capitol
ill to take a place at the table in health care redesign.
t this crucial time, all cardiovascular organizations and
embers need to stand together in proposing reform
ased on access, quality, and appropriate care. Divided,
e will have less influence and effect on the outcome.
The leadership of the ACC does not portend to sug-
est that we have been or always will be perfectly correct
nd that there is no room for improvement. We will al-
ays welcome legitimate constructive criticism and rec-
mmendations on how to do better because doing so is
art of what makes a stronger team.
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